Earnings: Abbott Laboratories (ABT) Shares Fall After Revenue Miss

0
Earnings: Abbott Laboratories (ABT) Shares Fall After Revenue Miss
By Abbott LaboratoriesUploaded by Gump Stump at en.wikipedia [Public domain], via Wikimedia Commons

Abbott Laboratories (NYSE:ABT) released its December quarter earnings this morning before opening bell, and investors appeared to be slightly disappointed, at least at first. Shares initially declined nearly 3% in premarket trading after the report, although they recovered slightly afterward.

Play Quizzes 4

Breaking down Abbott Laboratories’ results

The health care company reported lower net earnings of $589 million or 37 cents per share. In the same quarter a year ago, the company reported earnings of $1.053 billion or 66 cents per share. Net earnings from continuing operations excluding items did increase to $918 million or 58 cents per share, which is in line with consensus. Net sales rose .4% to $5.655 billion, compared to $5.632 billion in the same quarter a year ago. However, it wasn’t enough to meet Wall Street’s expectations.

This Too Value Fund Explains Why Turkey Is Ripe For Investment Right Now

TurkeyThe Talas Turkey Value Fund returned 9.5% net for the first quarter on a concentrated portfolio in which 93% of its capital is invested in 14 holdings. The MSCI Turkey Index returned 13.1% for the first quarter, while the MSCI All-Country ex-USA was down 5.4%. Background of the Talas Turkey Value Fund Since its inception Read More

Analysts had been expecting Abbott Laboratories (NYSE:ABT) to report earnings of 58 cents per share on revenue of $5.72 billion.

Abbott Laboratories (NYSE:ABT) reported worldwide sales for the fourth quarter of $5.7 billion—an increase of 3.3% on an operational basis. The company said its Diagnostics and Medical Devices division was the main driver of worldwide sales.

Abbott Laboratories provides guidance

The health care company said it plans to increase its share repurchases this year to over $ 2 billion. It also provided guidance for this year. Abbott Laboratories (NYSE:ABT) expects full-year earnings per share to be between $2.16 and $2.26 per share for 2014. At the midpoint of that range, it reflects double-digit growth. Analysts are currently projecting earnings of $2.21 per share for the full year.

Abbott Laboratories (NYSE:ABT) also said it expects full-year items to add up to about $1.03 per share. Those items include intangible amortization expense, charges from cost cutting plans and tax expenses from a repatriating 2014 earnings made outside the U.S. Including these items, the company expects GAAP earnings per share will be between $1,13 and $1.23 per share.

Updated on

Michelle Jones is editor-in-chief for ValueWalk.com and has been with the site since 2012. Previously, she was a television news producer for eight years. She produced the morning news programs for the NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spent a short time at the CBS affiliate in Huntsville. She has experience as a writer and public relations expert for a wide variety of businesses. Email her at Mjones@valuewalk.com.
Previous article Netflix, Inc. (NFLX), Groupon Inc (GRPN) Earnings Expected To Be Solid
Next article Facebook Inc (FB) COO Sandberg Becomes A Billionaire

No posts to display